Hologic, Inc.: Leiomyoma trials
The registry lists 16 Leiomyoma studies with Hologic, Inc. as lead sponsor. 0 are open to participants now and 7 have results posted.
No phase 16(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of FibroidsCompletedNCT02844920Results posted
- Sonography Guided Transcervical Ablation of Uterine FibroidsCompletedNCT02228174Not applicableResults posted
- Post Market Evaluation of Acessa With TAGTerminatedNCT01842789Not applicableResults posted
- MyoSure Hysteroscopic Tissue Removal System Registry StudyCompletedNCT01369758Not applicableResults posted
- HOME Study: Hysteroscopic Office Myomectomy EvaluationCompletedNCT01152112Not applicableResults posted
- Clinical Evaluation of the Interlace Medical Hysteroscopic MorcellatorCompletedNCT01026805Results posted
- Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine FibroidsCompletedNCT00874029Not applicableResults posted
- Transcervical Radiofrequency Ablation of Uterine Fibroids Global RegistryTerminatedNCT03118037
- Post Market TRUST - U.S.A. StudyCompletedNCT02163525Not applicable
- Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF AblationTerminatedNCT01998854
- Laparoscopic Uterine Sparing Techniques Outcomes and ReinterventionsCompletedNCT01750008Not applicable
- Post Market TRUST StudyCompletedNCT01563783Not applicable
- Fibroid Ablation Study - Large FibroidsTerminatedNCT01539187Not applicable
- Fibroid Ablation StudyTerminatedNCT01226290Not applicable
- Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal SystemCompletedNCT00979342Not applicable
- Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation StudyWithdrawnNCT00768742Not applicable